Cytokinetics, Incorporated (CYTK) Options Greeks
Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.
Cytokinetics, Incorporated (CYTK) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $10.23B, listed on NASDAQ, employing roughly 673 people, carrying a beta of 0.43 to the broader market. Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. Led by Robert I. Blum, public since 2004-04-26.
Snapshot as of Jun 30, 2026.
- Spot Price
- $85.53
- Net Gamma
- $8.1M
- Net Delta
- -$465.0M
- Net Vega
- -$1.2M
- ATM IV
- 39.7%
- Gamma Concentration
- 0.27
As of Jun 30, 2026, Cytokinetics, Incorporated (CYTK) aggregate Greeks are net delta -$465.0M, net gamma $8.1M, net vega -$1.2M, ATM IV 39.7%. Gamma concentration is 0.27: gamma is more dispersed, reducing any single-strike pinning force. Delta measures directional exposure, gamma measures the rate of delta change, and vega measures sensitivity to implied volatility. Net aggregate Greeks summarize the total dealer book across all strikes and expirations.
How CYTK options greeks Data Feeds Strategy Selection
Strategy selection on Cytokinetics, Incorporated options does not derive from any single metric in isolation. The options greeks view above sits inside a broader read: ATM IV currently sits at 39.7% and dealer gamma exposure is positive, so dealer hedging is mechanically mean-reverting. Combine the options greeks data here with the volatility-skew surface, dealer-gamma exposure, max-pain level, and upcoming-events calendar to build a positioning thesis. Risk-defined structures (credit spreads, debit spreads, iron condors) are usually safer than naked positions while the regime is uncertain; the data on this page anchors the inputs but does not by itself constitute a trade thesis.
How to read the CYTK Greeks profile
The chart above shows per-strike dealer-Greek exposures aggregated across calls and puts for the front expiration. Current net dealer gamma is $8.1M - a positive (mean-reverting) hedging regime. Net dealer delta of -$465.0M indicates short-delta dealer book - dealers are net short the underlying. Net vega of -$1.2M measures dealer P&L sensitivity to IV shifts - a 1-point IV move shifts book value by approximately $1.2M.
CYTK Greeks regime and dealer hedging
Aggregate dealer Greeks compress 4 sensitivities (delta, gamma, theta, vega) into a single read on hedging behavior. In the current positive-gamma regime, dealer hedging is structurally mean-reverting: as CYTK moves higher, dealers sell into rallies; as it moves lower, dealers buy into dips. This is the mechanical basis for the "pin to max pain" pattern. Gamma decays as expiration approaches; near-dated Greek exposures dominate the hedging flow.
Using CYTK Greeks data for strategy selection
The Greeks profile is the input to most quantitative options strategies. Premium-selling structures (covered calls, iron condors, cash-secured puts) are negative-gamma, positive-theta, negative-vega - they pay you for being patient about realized volatility but get hit when realized exceeds implied. Premium-buying structures (long calls, long puts, long straddles, ratio backspreads) are positive-gamma, negative-theta, positive-vega - they pay you when realized exceeds implied but bleed time decay otherwise. With CYTK IV rank at 0.7%, premium-buying has structural tailwind from cheap implied; pair with a directional thesis or event catalyst. Combine the regime read with the Greeks decomposition on this page to size structures correctly.
Learn how options Greeks is reported and how to read the data →
CYTK largest gamma exposure contracts
| Type | Strike | Expiration | Volume | OI | IV | Bid | Ask |
|---|---|---|---|---|---|---|---|
| CALL | $85.00 | Jul 17, 2026 | 41 | 7.9K | 39.7% | $3.30 | $3.60 |
| CALL | $80.00 | Jul 17, 2026 | 56 | 4.5K | 39.5% | $6.10 | $7.50 |
| CALL | $80.00 | Jan 15, 2027 | 1 | 13.9K | 52.9% | $16.20 | $17.90 |
Top 3 contracts from the institutional-grade nightly options scan; ranked by gex within the broader S&P 500/400/600 + ETF universe.
Frequently asked CYTK options greeks questions
- What are the CYTK aggregate Greek exposures?
- As of Jun 30, 2026, Cytokinetics, Incorporated (CYTK) snapshot Greeks are net delta -$465.0M, net gamma $8.1M, net vega -$1.2M. These aggregate the dealer book across all listed strikes and expirations under the standard customer-versus-dealer sign convention.
- What does the CYTK net dealer delta tell us?
- Net dealer delta of -$465.0M represents the directional exposure dealers carry from their option inventory. Dealers continuously hedge this exposure with stock, futures, or correlated instruments, so the size of net delta is also the size of hedge flow that will execute as spot moves.
- How do CYTK Greeks inform hedging?
- Delta tracks first-order directional exposure; gamma tracks how quickly delta changes; vega tracks IV sensitivity. Aggregated dealer Greeks let traders read the dealer-positioning regime: long-gamma regimes mean-revert moves; short-gamma regimes amplify them. Vega exposure indicates how dealer P&L responds to vol shocks and hence the direction of vol-shock hedging flows.